Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.

An oxygen-generating implant keeps high-density insulin-producing cells alive in diabetic rats for months without immune suppression.

Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.

The enhanced hybrid model improves the predictive capability of data-driven modeling and reduces the need for process knowledge.

AIs are as much a tool as a hammer or shovel, but to find the opportunities, we need to understand what the realities and risks are.

In search of a better approach to designing and developing these small proteins, researchers turned to ProtGPT2.

Surging demand for vectors has also prompted suppliers to explore novel transfection technologies—including electroporation or transposon-based systems—to improve yield. Traditional methods rely on ...

The AI tool, named “Pythia,” predicts how cells repair their DNA after CRISPR editing and opens the door to next-generation gene therapies.